Exact Sciences
EXAS
#1383
Rank
ยฃ9.97 B
Marketcap
ยฃ53.97
Share price
2.34%
Change (1 day)
-11.39%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of June 2024 : ยฃ2.43 B

According to Exact Sciences's latest financial reports the company has ยฃ2.43 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ2.46 B-1.85%
2022-12-31$ยฃ2.51 B0.49%
2021-12-31$ยฃ2.50 B52.85%
2020-12-31$ยฃ1.63 B-5.02%
2019-12-31$ยฃ1.72 B223.07%
2018-12-31$ยฃ0.53 B38.59%
2017-12-31$ยฃ0.38 B41.71%
2016-12-31$ยฃ0.27 B23.33%
2015-12-31$ยฃ0.22 B18.69%
2014-12-31$ยฃ0.18 B126.56%
2013-12-31$ยฃ81.93 M34.38%
2012-12-31$ยฃ60.97 M13.5%
2011-12-31$ยฃ53.71 M3.63%
2010-12-31$ยฃ51.83 M1265.47%
2009-12-31$ยฃ3.79 M-324.99%
2008-12-31$-ยฃ1.69 M-153.58%
2007-12-31$ยฃ3.14 M-58.76%
2006-12-31$ยฃ7.63 M-46.51%
2005-12-31$ยฃ14.27 M-27.9%
2004-12-31$ยฃ19.8 M187.2%
2003-12-31$ยฃ6.89 M-71.17%
2002-12-31$ยฃ23.91 M-41.19%
2001-12-31$ยฃ40.66 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ0.56 B-76.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.86 B-64.52%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.22 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ59.62 B 2,351.21%๐Ÿ‡ซ๐Ÿ‡ท France